- Company Overview for CENTESSA PHARMACEUTICALS (MORPHOGEN-IX) LIMITED (09686738)
- Filing history for CENTESSA PHARMACEUTICALS (MORPHOGEN-IX) LIMITED (09686738)
- People for CENTESSA PHARMACEUTICALS (MORPHOGEN-IX) LIMITED (09686738)
- Charges for CENTESSA PHARMACEUTICALS (MORPHOGEN-IX) LIMITED (09686738)
- More for CENTESSA PHARMACEUTICALS (MORPHOGEN-IX) LIMITED (09686738)
Date (document was filed at Companies House) | Type | Description (of the document filed at Companies House) | View / Download (PDF file, link opens in new window) |
---|---|---|---|
04 Jul 2022 | SH10 | Particulars of variation of rights attached to shares | |
23 Jun 2022 | AP01 | Appointment of David Min Chao as a director on 17 June 2022 | |
15 Mar 2022 | SH01 |
Statement of capital following an allotment of shares on 14 March 2022
|
|
10 Jan 2022 | PSC05 | Change of details for Centessa Pharmaceuticals Limited as a person with significant control on 14 May 2021 | |
07 Jan 2022 | PSC05 | Change of details for Centessa Pharmaceuticals Limited as a person with significant control on 4 May 2021 | |
07 Jan 2022 | PSC05 | Change of details for United Medicines Biopharma Limited as a person with significant control on 17 February 2021 | |
05 Jan 2022 | PSC05 | Change of details for United Medicines Biopharma Limited as a person with significant control on 29 January 2021 | |
30 Nov 2021 | TM01 | Termination of appointment of Saurabh Saha as a director on 30 November 2021 | |
30 Nov 2021 | AD01 | Registered office address changed from C/O the Cambridge Partnership Ltd, the Dorothy Hodgkin Building Babraham Research Campus, Babraham Cambridge CB22 3FH United Kingdom to 3rd Floor 1 Ashley Road Altrincham Cheshire WA14 2DT on 30 November 2021 | |
30 Nov 2021 | AP04 | Appointment of Oakwood Corporate Secretary Limited as a secretary on 30 November 2021 | |
30 Nov 2021 | AP01 | Appointment of David John Grainger as a director on 30 November 2021 | |
05 Nov 2021 | TM02 | Termination of appointment of the Cambridge Partnership Limited as a secretary on 1 November 2021 | |
24 Oct 2021 | RESOLUTIONS |
Resolutions
|
|
21 Oct 2021 | MR01 | Registration of charge 096867380003, created on 4 October 2021 | |
19 Oct 2021 | MR01 | Registration of charge 096867380002, created on 1 October 2021 | |
15 Oct 2021 | MR01 | Registration of charge 096867380001, created on 4 October 2021 | |
30 Sep 2021 | AA | Total exemption full accounts made up to 31 December 2020 | |
11 Aug 2021 | CS01 |
Confirmation statement made on 14 July 2021 with updates
|
|
15 Apr 2021 | AA01 | Previous accounting period extended from 31 July 2020 to 31 December 2020 | |
23 Feb 2021 | RESOLUTIONS |
Resolutions
|
|
23 Feb 2021 | MA | Memorandum and Articles of Association | |
23 Feb 2021 | MA | Memorandum and Articles of Association | |
23 Feb 2021 | RESOLUTIONS |
Resolutions
|
|
12 Feb 2021 | SH03 | Purchase of own shares. | |
11 Feb 2021 | PSC02 | Notification of United Medicines Biopharma Limited as a person with significant control on 29 January 2021 |